Gel to improve healing after removal of harmless skin spots
Part of Skin clinical trials.
This study tests a new gel called LUT017 to see if it helps skin wounds heal better and faster after removal of harmless skin spots (like moles). It is for healthy adults having at least two benign skin lesions removed, and the gel is applied to the wounds to improve healing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 or older and generally in good health.
- You need to have at least two harmless skin spots (like moles) that will be removed to study the gel on the wounds.
- You must not have a history of poor wound healing, such as keloid scars or chronic sores.
- You cannot have any infection in the wound area or be taking antibiotics for skin or bone infections.
- You cannot be actively getting chemotherapy or radiation for cancer, and you cannot be taking certain cancer drugs (BRAF inhibitors) within the last month.
- If you could become pregnant, you must have a negative pregnancy test and use very effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new way to help wounds heal by using a special material that supports the skin's natural repair process. It is for people with different types of wounds that need surgery, like burns, cuts, or chronic sores.
This study tests a new gel that may help heal leg ulcers caused by poor vein circulation. The gel is applied directly to the wound and aims to trigger natural healing processes in the skin.
This study tests a medication called Verteporfin, which may improve how surgical wounds heal. It is given during surgery to remove a type of skin cancer or precancerous lesion, and the researchers will see if it helps the wound heal better.
This study tests a device that uses a special light to image skin lesions after applying an FDA-approved cream. It aims to see if the device can help doctors see benign skin growths more clearly before they are removed.
This study tests an experimental drug called FLD-103 injected into a specific type of skin cancer (nodular basal cell carcinoma) that hasn't been treated before. The goal is to see if it helps remove the cancer before final surgery.
This Phase 1 study looks at genetic risk factors in children with unusual skin lesions. The goal is to help doctors better decide which spots should be closely watched or safely biopsied.
Hear when a new Wound Healing trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.